Why Did Novavax Stock Decline 20% In December?

Vaccine specialist Novavax - which is seen as a key player in the Covid-19 vaccine space - saw its stock price decline by about 20% over December. Here are a few possible reasons for the decline. Covid-19 vaccines by Pfizer and Moderna received emergency approval from the U.S. FDA in December...